Skip navigation

The stress stability of olanzapine: studies of interactions with excipients in solid state pharmaceutical formulations

The stress stability of olanzapine: studies of interactions with excipients in solid state pharmaceutical formulations

Djordjević Filijović, Nataša, Antonijević, Milan D., Pavlović, Aleksandar, Vučković, Ivan, Nikolić, Katarina and Agbaba, Danica (2015) The stress stability of olanzapine: studies of interactions with excipients in solid state pharmaceutical formulations. Drug Development and Industrial Pharmacy, 41 (3). pp. 502-514. ISSN 0363-9045 (Print), 1520-5762 (Online) (doi:10.3109/03639045.2014.884114)

[img] PDF (Publisher's PDF Proofs)
11370 ANTONIJEVIC_Stress_Stability of_Olanzapine_2015.pdf - Published Version
Restricted to Registered users only

Download (601kB)

Abstract

Stress stability testing represents an important part of the drug development process. It is used as an important tool for the identification of degradation products and degradation pathways, as well as for the assessment of changes in physical form of drug molecules. The impact of excipients on the stability of olanzapine confirms that levels of impurities and degradants are limiting parameters and are therefore used for stability evaluation. The major degradation product of olanzapine was identified as 2-methyl-5,10-dihydro-4H-thieno[2,3-b][1,5]benzodiazepine-4-one (III). The structure of III was determined by using LC-MS, IR and NMR. Compatibility and stress stability results demonstrated that tablet formulations of olanzapine are sensitive to temperature and moisture. In samples protected from moisture, the increase in concentration of III was shown to be highly temperature dependent and the degradation followed zero-order kinetics. In addition, studies of olanzapine with excipients and in formulated tablets revealed polymorphic phase changes in some samples, influenced by a combination of stress temperature and humidity conditions. Polymorphic transitions were monitored using x-ray powder diffraction (XRPD) analysis and exhibited no correlation between the phase change (appearance of a new polymorph) and the degradation process.

Item Type: Article
Uncontrolled Keywords: drug–excipient interactions, impurities, olanzapine, polymorphism, stress testing
Subjects: R Medicine > RS Pharmacy and materia medica
Faculty / Department / Research Group: Faculty of Engineering & Science
Faculty of Engineering & Science > Department of Pharmaceutical, Chemical & Environmental Sciences
Related URLs:
Last Modified: 11 Apr 2017 08:45
Selected for GREAT 2016: GREAT b
Selected for GREAT 2017: None
Selected for GREAT 2018: None
URI: http://gala.gre.ac.uk/id/eprint/11370

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics